A trial has heard a Canterbury woman fatally stabbed her estranged husband repeatedly in the chest and through the heart, before storing his body - dressed in his underwear - in a cupboard in her ...
The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...
Michael Kennedy: "We've really hit an amazing stride in terms of basket innovation, and we've really embraced some new technology to help us do that." ...
CEO Jan Mikkelsen highlighted 2024 as a pivotal year, with SKYTROFA achieving €200 million in revenue and a 6.5% share of the U.S. growth hormone market. The product now holds 45% of the U.S.
Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million– Following ...
Q32 Bio (QTTB) announced a corporate restructuring to focus on the advancement of its bempikibart clinical development program for the ...
Ole Miss beat LSU in SEC play this college basketball season in a huge comeback. Sean Pedulla and Dre Davis led the Rebels to ...
Welcome to Basket Bros, the ultimate basketball game where you can engage in action-packed 1v1 matches. Show off your dribbling, shooting, and dunking skills in this unblocked version, playable ...
2 Department of Rheumatology, VU University Medical Centre, Amsterdam, The Netherlands 3 Department of Clinical Epidemiology and Biostatistics, VU University Medical Centre, Amsterdam, The Netherlands ...
Additional gains in endurance time and reductions in symptoms of dyspnoea were observed during an endurance cycling test (secondary outcome) Trial registration number NCT01397396; Results.
Design Single centre randomised controlled trial. Setting Level III neonatal intensive care unit at the Coombe Women and Infants University Hospital, Dublin, Ireland. Patients Very low birthweight ...
Methods A total of 128 patients were recruited for this multicentre, prospective, parallel, randomised controlled trial and were distributed in three arms (general recommendations, inactive and active ...